Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary E Hall

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncotargets and Therapy|May 21, 2020
Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic LandscapeMary E Hall, Heather L Huelster, Amy N Luckenbaugh, et al.
Cancer Causes & Control : CCC|May 8, 2021
Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approachMary E Hall, Bimal Bhindi, Amy N Luckenbaugh, et al.
Clinical Genitourinary Cancer|May 26, 2023
Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of RCTsMary E Hall, Whitney J Padgett, Zachary Klaassen, et al.
Urology|October 4, 2021
Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder CancerWilson Sui, Mary E Hall, Daniel A Barocas, et al.
Journal of the American College of Surgeons|April 22, 2021
Women as Authors of Randomized Controlled Trials of Minimally Invasive Surgery: Systematic Review and Meta-Analysis of 3 Decades of TrialsRashid K Sayyid, Soum D Lokeshwar, Amy N Luckenbaugh, et al.
Urologic Oncology|October 25, 2021
Association between prior nephrectomy and efficacy of immune checkpoint inhibitor therapy in metastatic renal cell carcinoma - A systematic review and meta-analysisRaj Satkunasivam, Jonathan Ca Guzman, Zachary Klaassen, et al.
Cancer|June 23, 2021
Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort studyKyle A Dymanus, Mohit Butaney, Diana E Magee, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncotargets and Therapy|May 21, 2020
Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic LandscapeMary E Hall, Heather L Huelster, Amy N Luckenbaugh, et al.
Cancer Causes & Control : CCC|May 8, 2021
Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approachMary E Hall, Bimal Bhindi, Amy N Luckenbaugh, et al.
Clinical Genitourinary Cancer|May 26, 2023
Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of RCTsMary E Hall, Whitney J Padgett, Zachary Klaassen, et al.
Urology|October 4, 2021
Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder CancerWilson Sui, Mary E Hall, Daniel A Barocas, et al.
Journal of the American College of Surgeons|April 22, 2021
Women as Authors of Randomized Controlled Trials of Minimally Invasive Surgery: Systematic Review and Meta-Analysis of 3 Decades of TrialsRashid K Sayyid, Soum D Lokeshwar, Amy N Luckenbaugh, et al.
Urologic Oncology|October 25, 2021
Association between prior nephrectomy and efficacy of immune checkpoint inhibitor therapy in metastatic renal cell carcinoma - A systematic review and meta-analysisRaj Satkunasivam, Jonathan Ca Guzman, Zachary Klaassen, et al.
Cancer|June 23, 2021
Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort studyKyle A Dymanus, Mohit Butaney, Diana E Magee, et al.
Pageof 2